National Conference of the Italian Group for the Study of Neuromorphology
Vol. 70 No. s2 (2026): 36th National Conference of the Italian Group for the Study of...

P029 | MIDBRAIN DOPAMINE DEPLETION ALTERS MEDIAL PREFRONTAL CORTEX FUNCTION: INVESTIGATED BY IN VIVO THREE-PHOTON IMAGING AND EX VIVO PATCH-CLAMP RECORDINGS

S. Ficchì1, P. Krashia2|3, G. Loffredo1, I. Ferrari1, L. Saba1, L. La Barbera1|2, M. Fuhrmann4, M. D'Amelio1|2 | 1Department of Medicine and Surgery, Laboratory of Molecular Neuroscience, Campus Bio-Medico University of Roma, Italy; 2Department of Experimental Neurosciences, LIFE - Istituto Ricerca Cura - Santa Lucia IRCCS, Rome, Italy; 3Department of Sciences and Bio-Technologies, Campus Bio-Medico University of Roma, Italy; 4Department of Neuroimmunology and Imaging, German Center for Neurodegenerative Diseases, Bonn, Germany

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 20 November 2026
0
Views
0
Downloads

Authors

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder in which alterations of the mesocorticolimbic dopaminergic (DA) system have been reported. In particular, the ventral tegmental area (VTA) shows reduced volume and connectivity in patients with mild cognitive impairment and AD. In line with this, the Tg2576 mouse model of AD shows a progressive loss of VTA DAergic neurons from 2-3 months of age, long before β-amyloid deposition. The medial prefrontal cortex (mPFC), which supports executive control and working memory, receives dense DAergic input, but whether reduced DA alone is sufficient to compromise its function remains unclear. To isolate the contribution of midbrain DA, we used a selective 6-hydroxydopamine (6-OHDA) lesion. Mice were injected with a viral construct expressing jGCaMP8s under the CaMKIIa promoter in the mPFC and, one week later, received a cranial window and a unilateral 6-OHDA lesion of the VTA. Four weeks later, the activity of pyramidal neurons in the deep layers (V–VI) of the prelimbic cortex was recorded by in vivo three-photon (3P) calcium imaging in awake, head-fixed mice. Post-mortem analysis confirmed the DAergic lesion, the reduced DAergic fibres in the mPFC and the sparing of noradrenergic fibres. To interpret the in vivo findings, we also performed patch-clamp recordings in mPFC slices from 6-OHDA and control mice. In vivo 3P imaging showed that neurons of 6-OHDA mice had a significantly higher resting firing rate and lower local synchronization, fragmenting the network into smaller functional clusters, and a weaker coupling between mPFC activity and pupil dilation. Patch-clamp recordings showed that pyramidal neurons of lesioned mice were hyperexcitable: they fired more action potentials to depolarizing current steps, had a higher membrane resistance and entered depolarization block earlier. Intrinsic hyperexcitability can account for the higher resting activity, whereas the early depolarization block reflects the shorter firing bouts recorded in vivo, leading to local desynchronization. Thus, midbrain DA loss alone, in the absence of amyloid pathology, is sufficient to make mPFC circuits hyperactive and desynchronized, suggesting an early role of DAergic dysfunction in the cortical alterations of AD. To our knowledge, this is the first application of in vivo 3P imaging to the deep layers of the prelimbic cortex in a DA-depletion model, providing a network-level view of DAergic dysfunction in awake mice.

Downloads

Download data is not yet available.

Citations

How to Cite



1.
P029 | MIDBRAIN DOPAMINE DEPLETION ALTERS MEDIAL PREFRONTAL CORTEX FUNCTION: INVESTIGATED BY IN VIVO THREE-PHOTON IMAGING AND EX VIVO PATCH-CLAMP RECORDINGS: S. Ficchì1, P. Krashia2|3, G. Loffredo1, I. Ferrari1, L. Saba1, L. La Barbera1|2, M. Fuhrmann4, M. D’Amelio1|2 | 1Department of Medicine and Surgery, Laboratory of Molecular Neuroscience, Campus Bio-Medico University of Roma, Italy; 2Department of Experimental Neurosciences, LIFE - Istituto Ricerca Cura - Santa Lucia IRCCS, Rome, Italy; 3Department of Sciences and Bio-Technologies, Campus Bio-Medico University of Roma, Italy; 4Department of Neuroimmunology and Imaging, German Center for Neurodegenerative Diseases, Bonn, Germany. Eur J Histochem [Internet]. 2026 Nov. 20 [cited 2026 Nov. 20];70(s2). Available from: https://www.ejh.it/ejh/article/view/4849